QT
BIOR

Quantbot Technologies’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Quantbot Technologies’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18
Closed -$24K – 1872
2020
Q4 		$24K Buy
+18
New +$26.4K ﹤0.01% 988

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's BIOR Position: Q1 2021 in Review

Quantbot Technologies sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2021, closing a stake of 18 shares — an estimated $24K sold.

Quantbot Technologies first reported a position in BIOR in Q4 2020 and held it in 1 quarter. The position peaked at $24K in Q4 2020. 47 funds tracked by Wall St. Rank hold BIOR as of Q1 2021.

  • Quantbot Technologies reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Quantbot Technologies sold 18 Biora Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $24K.
  • Quantbot Technologies first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Quantbot Technologies's Biora Therapeutics, Inc. Common Stock position peaked at $24K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Quantbot Technologies's 13F filing for Q1 2021, filed 14 May 2021.